SCHEMBL25790320

SCHEMBL25790320

CNS(=O)(=O)c1ccc(Nc2ccc(C(C)(P)P)cc2)c(-c2nnn(Cc3ccccc3F)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 2/20 0.43
▸ YAP1 P46937 1/20 0.43
▸ MAPT P10636 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ RECQL P46063 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ECE1 P42892 1/20 0.35
▸ ALDH3A1 P30838 1/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20779713 0.92 TEAD1 (0.52) TEAD1YAP1MAPTALDH1A1NPC1
SCHEMBL20779823 0.85 MAPT (0.45) TEAD1YAP1MAPTALDH1A1NPC1
SCHEMBL22635667 0.81 ATM (0.48) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL29901815 0.81 ATM (0.48) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL20779824 0.79 NPC1 (0.52) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL30411362 0.79 NPC1 (0.52) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL20779643 0.78 TEAD1 (0.59) TEAD1YAP1MAPTALDH1A1SMN1; SMN2
SCHEMBL20766317 0.78 MAPT (0.46) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL25790133 0.77 TEAD1 (0.46) TEAD1YAP1MAPTALDH1A1NPC1
SCHEMBL25789977 0.77 TEAD1 (0.55) TEAD1YAP1MAPTALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192607-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192607-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF TEAD1, TEAD4, TEAD2 TEAD1 1/4885YAP1 9/4885MAPT 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback